Humana Inc. (NYSE:HUM) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC trimmed its holdings in Humana Inc. (NYSE:HUM) by 0.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 678,971 shares of the insurance provider’s stock after selling 2,294 shares during the quarter. Allspring Global Investments Holdings LLC owned 0.56% of Humana worth $171,545,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently made changes to their positions in HUM. FNY Investment Advisers LLC lifted its stake in Humana by 6,647.5% during the fourth quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after purchasing an additional 26,856 shares during the last quarter. Retirement Systems of Alabama increased its holdings in shares of Humana by 735.9% in the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after buying an additional 192,801 shares in the last quarter. PDT Partners LLC lifted its position in shares of Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock valued at $1,286,000 after acquiring an additional 2,660 shares during the last quarter. Secure Asset Management LLC acquired a new position in shares of Humana in the 4th quarter worth $244,000. Finally, Ontario Teachers Pension Plan Board lifted its stake in Humana by 6.5% during the third quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after buying an additional 71,910 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the stock. Wells Fargo & Company dropped their target price on shares of Humana from $387.00 to $290.00 and set an “overweight” rating on the stock in a research report on Monday, November 4th. Barclays lifted their price objective on shares of Humana from $253.00 to $255.00 and gave the stock an “equal weight” rating in a research report on Wednesday, January 22nd. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and increased their target price for the company from $247.00 to $308.00 in a report on Wednesday, November 6th. Truist Financial lifted their price target on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Finally, TD Cowen increased their price objective on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $297.68.

Humana Stock Performance

Shares of HUM opened at $256.69 on Wednesday. The firm has a market cap of $30.91 billion, a price-to-earnings ratio of 22.74, a price-to-earnings-growth ratio of 2.11 and a beta of 0.56. The company’s fifty day moving average is $273.69 and its 200-day moving average is $296.67. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $406.46.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities analysts expect that Humana Inc. will post 16.11 EPS for the current fiscal year.

Insider Buying and Selling

In other Humana news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction that occurred on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total value of $948,930.78. Following the transaction, the insider now directly owns 8,181 shares of the company’s stock, valued at $2,096,463.06. The trade was a 31.16 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.32% of the stock is owned by insiders.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.